|
|
|
|
|
LONDON, Aug 3, 2021 - (ACN Newswire) - The ClinTex (CTi) tokenized platform (clintex.io) will be the first of its kind to utilize blockchain-based clinical data analytics to address the main causes of clinical trial inefficiency, helping to drive down the cost of new medicines and expediting their delivery to patients.
 | | ClinTex (CTi) launches 'Operational Excellence Module' (CTi-OEM) - a blockchain clinical trial application to tackle clinical trial inefficiencies and high costs. (ClinTex) |
The initial spark of an idea that would eventually become ClinTex started in 2014, at the DIA Forum in Vienna. By 2018, Clintex was formally working on the Clinical Trials Intelligence (CTi) platform. CTi's purpose is to deliver data analysis at scale, to drive collaboration and insights across clinical trials.
With large pharma companies like Merck and Novartis already testing blockchain as a technology of the future to support their clinical trial strategy for patient information and to manage clinical trial medication, this paves the way for ClinTex CTi to partner with the industry to deliver more innovative and impactful uses of blockchain to increase clinical trial efficiency.
The CTi-OEM App
Leveraging 50+ years of medicine development experience, ClinTex has moved at a breakneck pace to launch its first blockchain clinical trial app of the CTi Platform, the Operational Excellence Module (CTi-OEM). CTi-OEM provides intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote staff; allowing in-stream decision-making on what actions are required to ensure a successful investigation into the safety and efficacy of new medicines.
Using the CTi-OEM console, researchers can deep dive into clinical trial data and take proactive action to make clinical trials run more efficiently. These operational issues include things like clinical protocol deviations and adverse events relating to patient safety in the clinical trial.
The company has prioritized the development of the CTi-OEM blockchain clinical trial app to target some of the major causes of inefficiency in clinical trials, enabling its first app to derive maximum tangible benefits for the pharma and clinical trials industry. CTi-OEM achieves this through a comprehensive portfolio of tools, which is accessible through the CTi-OEM console.
Compliance Requirements & Patient Safety
One of the major obstacles to a successful clinical trial is adherence to the clinical trial protocol. Analytics within the CTi-OEM application allows the detection and analysis of these deviations and allows the clinical trial team to take speedy action. These tools provide powerful insights into the major causes of non-compliance in clinical trials providing analytics to help clinical trial teams identify and resolve them to speed up progress.
Protecting patient safety during a clinical trial is the most important aspect in the development of any new medicine. Adverse events are safety issues that occur during the testing of a new medicine. CTi-OEM provides valuable insight into patient safety throughout a clinical trial. For example, adverse event rate per site allows the clinical trial team to identify those sites that have a high rate of safety events which may point to procedural problems or may also uncover safety risks that need further investigation.
These are just a few examples of CTi-OEM's toolkit. For more information on CTi-OEM, there is a series of demonstration videos that give an overview of the platform, and how it can help alleviate pain points in clinical trials. Any clinical trial professionals interested in learning more or becoming early adopters can email ClinTex at industry@clintex.io or visit http://clinicaltrialsintelligence.org.
First Clinical Trials app on the CTi Platform
CTi-OEM is just the beginning for ClinTex offerings. Eventually, the platform will consist of 7 different blockchain clinical trial applications that derive intelligent analytics from all types of clinical trial data, and it is these analytics that can be used to drive efficiency in clinical trials. The ClinTex roadmap is on track to have live client onboarding and revenue generation by the end of 2022.
ClinTex Socials
Twitter : https://twitter.com/ClinTexCTi
Telegram : https://t.me/ClinTexCTi
Medium : https://medium.com/clintexcti
YouTube : https://youtu.be/iK3zkhsDzzA
Website : https://clintex.io/
Contact Details
Email: press@clintex.io
About ClinTex
ClinTex CTi (Clinical Trials Intelligence) is a solution provider to the pharmaceutical industry, a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials. Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.
Topic: Press release summary
Source: ClinTex (CTi)
Sectors: Healthcare & Pharm, Blockchain Technology, Clinical Trials
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
Hong Kong delegation concludes ASEAN mission in Vietnam
Aug 2, 2024 19:36 HKT/SGT
|
|
|
Local Wellness Consciousness Continues to Flourish - Glow Festival by Prudential 2024 Concludes 16 Days of Wellness Awakening with 400% Increase in Attendance 
Aug 2, 2024 18:00 HKT/SGT
|
|
|
Expleo, AI partner, to honour Philippines financial services pioneers at World Financial Innovation Series
Aug 2, 2024 17:08 HKT/SGT
|
|
|
Airlangga Alumnus Provides Digital Journalism Inspiration
Aug 2, 2024 17:00 HKT/SGT
|
|
|
SMI Vantage and The9 Limited Sign Cooperation Agreement to Expand Digital Mining and AI Collaboration
Aug 2, 2024 17:00 HKT/SGT
|
|
|
Honda to Launch New Motorsports Website, Exhibit RA271 and Demo-Run RA272 to Commemorate 60th Anniversary Since First F1 Participation
Friday, August 2, 2024 2:39:00 PM
|
|
|
MHI Revises Green/Transition Finance Framework and Issues The Third Series of MHI Transition Bonds
Friday, August 2, 2024 2:09:00 PM
|
|
|
Fujitsu SX Survey 2024: The latest trends in global CxO's AI and sustainability initiatives
Friday, August 2, 2024 10:01:00 AM
|
|
|
TransNusa Becomes First Foreign Airline to Launch Flights from Jakarta to Subang Airport in Malaysia
Aug 2, 2024 10:00 HKT/SGT
|
|
|
Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) 2024 Q2
Aug 2, 2024 08:50 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
